Merck, the second-biggest U.S. drugmaker, on Wednesday said outside monitors recommended that its late-stage study of odanacatib, a new type of treatment, be stopped early because data has already shown it reduces fractures. Shares of Merck rose 4.2 percent on Thursday, on boosted hopes for the medi

The findings published in the New England Journal of Medicine could fuel a political furor over new plans for a nationwide expansion of Medicaid that erupted after the U.S. Supreme Court’s ruling to uphold President Barack Obama’s healthcare law in late June.In an unexpected move, the high court rul

About the study Objective: This study aimed to quantify heterogeneity in the value for money of precision medicine (PM) by application types across contexts and conditions and to quantify sources of heterogeneity to areas of particular promises or concerns as the field of PM moves forward. Methods

(Reuters Health) – When people with chronic health conditions have lower out-of-pocket costs for medications, they are more likely to actually fill their prescriptions, according to a new research review.The findings, reported in the Annals of Internal Medicine, sound logical. But they lend some har

CHICAGO — Taking periodic breaks from a commonly used treatment for prostate cancer could shorten men’s lives, researchers reported here on SaturdayIn a large study, intermittent hormonal therapy proved to be less effective than continuous therapy for certain men with metastatic prostate cancer.The

    Concern over drug-resistant strains of TB is growing, with similar ‘incurable’ TB emerging in Italy and Iran. Doctors in Mumbai said 12 patients had a “totally drug resistant” form of the infection, and three have died.The Indian Health Ministry is investigating the cases and has sent a team of

CHICAGO — A drug that delivers a powerful poison to tumors without some of the side effects of traditional treatments can delay the worsening of breast cancer and also appears to substantially prolong lives, according to results of a study presented here Saturday.Besides representing an advance in t

This project is part of the international Decision Support Initiative (iDSI), an innovative global partnership between leading government institutions, universities, and think tanks in the field of healthcare priority-setting. iDSI uniquely provides intellectual insight with hands-on field expertise, and delivers peer-to-peer support to policymaker

หลักประกันสุขภาพถ้วนหน้าช่วยให้คนไทยได้รับการรักษาโดยไม่ต้องกังวลเรื่องค่ารักษาพยาบาลมากนัก ทว่ามีประเด็นหลายด้านที่ต้องขบคิด ทั้งค่ารักษาที่รัฐต้องจ่าย ความเป็นไปได้ในทางปฏิบัติของนโยบาย จนถึงวิธีรักษาที่ต้องได้มาตรฐาน สิ่งสำคัญคือ หลักประกันสุขภาพถ้วนหน้าของไทยต้องไม่ทิ้งใครไว้ข้างหลัง และเพื่อให้

(Reuters Health) – A study of nearly 190,000 young women injected with Merck & Co’s human papillomavirus vaccine Gardasil found no new safety concerns.Researchers said the only side effects they observed – rare cases of skin infections and fainting – were benign and expected.“This analysis was v